KP
HCA icon

Keel Point’s HCA Healthcare HCA Stock Holding History

Keel Point’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484K Sell
1,240
-30
-2% -$12.7K 0.03% 297
2026
Q1 		$601K Sell
1,270
-327
-20% -$165K 0.04% 241
2025
Q4 		$746K Sell
1,597
-161
-9% -$74.8K 0.04% 226
2025
Q3 		$749K Buy
1,758
+13
+0.7% +$5.04K 0.05% 225
2025
Q2 		$669K Buy
1,745
+174
+11% +$62.7K 0.04% 240
2025
Q1 		$543K Buy
1,571
+104
+7% +$33.4K 0.04% 237
2024
Q4 		$440K Sell
1,467
-354
-19% -$124K 0.04% 259
2024
Q3 		$740K Buy
1,821
+273
+18% +$100K 0.06% 180
2024
Q2 		$571K Buy
1,548
+63
+4% +$20.5K 0.05% 207
2024
Q1 		$495K Buy
1,485
+5
+0.3% +$1.53K 0.05% 202
2023
Q4 		$401K Sell
1,480
-4
-0.3% -$989 0.05% 220
2023
Q3 		$365K Sell
1,484
-52
-3% -$14.2K 0.05% 205
2023
Q2 		$466K Buy
1,536
+102
+7% +$28.4K 0.06% 171
2023
Q1 		$378K Buy
1,434
+4
+0.3% +$1.02K 0.05% 195
2022
Q4 		$343K Buy
+1,430
New +$320K 0.05% 199

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Keel Point's HCA Position: Q2 2026 in Review

Keel Point reduced its HCA Healthcare (HCA) stake by 2.4% in Q2 2026, selling an estimated $12.7K and leaving 1,240 shares worth $484K. The position accounts for 0.03% of the portfolio, ranked #297.

Keel Point first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $749K in Q3 2025. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Keel Point held 1,240 shares of HCA Healthcare worth $484K as of Q2 2026.
  • Keel Point sold 30 HCA Healthcare shares in Q2 2026, an estimated $12.7K.
  • HCA Healthcare made up 0.03% of Keel Point's portfolio in Q2 2026, its #297 holding.
  • Keel Point first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Keel Point's HCA Healthcare position peaked at $749K in Q3 2025.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Keel Point's 13F filing for Q2 2026, filed 14 Aug 2026.